|
| Press Releases |
|
 |
|
| Friday, October 19, 2018 |
|
|
Novotech and CNS deal expands CRO services for Biopharma Clients across Asia-Pacific |
| Novotech, the largest Asia-Pacific-based CRO, has acquired Australasian specialist CRO Clinical Network Services (CNS), as part of a mutual mission to expand services to biopharma for early phase product development and clinical research through to later phase regional and global trials. more info >> |
|
| Thursday, August 23, 2018 |
|
|
Novotech the Asia-Pacific CRO named Top 10 CRO |
| Asia-Pacific specialist CRO Novotech has been selected as one of the Top 10 CROs globally by leading industry media magazine Pharma Tech Outlook. more info >> |
|
| Thursday, August 9, 2018 |
|
|
Sponsors Recommend Novotech for CRO Leadership Award |
| Asia-Pacific specialist CRO Novotech has been awarded the "Exceeded Customer Expectations" Award by Life Science Leader magazine based on findings from sponsor companies that utilise outsourcing services. In particular, Novotech was recognised for its local market/regulatory knowledge and for meeting timelines. more info >> |
|
| Thursday, July 19, 2018 |
|
|
Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical Trials |
| Asia-Pacific specialist CRO Novotech announced today it has partnered with the Asian Eye Institute Inc (AEI), a private eye center in the Philippines, to facilitate high-quality and rapid feasibility, start-up and recruitment processes for its ophthalmology clients. more info >> |
|
| Thursday, June 28, 2018 |
|
|
Novotech at DIA18 announces Asia Partnerships on Target to Reach 1.4 Bil Patients |
| Asia-Pacific CRO Novotech announced today at DIA Global Annual Meeting (24-28 June, Boston Convention and Exhibition Center) that it has signed Memorandum of Understandings (MOU) with five of the leading medical institutions in the region. more info >> |
|
| Friday, June 15, 2018 |
|
|
Novotech signs MoU with CMUH Taiwan to offer Enhanced Services for Global Trials |
| Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MoU) with the China Medical University Hospital (CMUH) in Taiwan to facilitate high-quality and rapid feasibility, start-up and recruitment processes. http://www.cmuh.cmu.edu.tw/ more info >> |
|
| Monday, June 18, 2018 |
|
|
Novotech與中國醫藥大學附設醫院 (台灣) 締結MOU為全球試驗提供增效服務 |
| 亞太專業級合約研究機構(CRO) Novotech今日宣布已與中國醫藥大學附設醫院(CMIUH，台灣)締結一份諒解備忘錄(MOU)，旨在助力高質量、快速的項目可行性研究、啟動和招募流程。 http://www.cmuh.cmu.edu.tw more info >> |
|
| Tuesday, June 12, 2018 |
|
|
Novotech与中国医药大学附设医院（台湾）缔结MOU为全球试验提供增效服务 |
| 亚太专业级合约研究机构(CRO) Novotech今日宣布已与中国医药大学附设医院(CMIUH，台湾)缔结一份谅解备忘录(MOU)，旨在助力高质量、快速的项目可行性研究、启动和招募流程。http://www.cmuh.cmu.edu.tw more info >> |
|
|
Novotech Signs MOU with China Medical University Hospital in Taiwan to Offer Enhanced Services for Global Trials |
| Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with the China Medical University Hospital (CMUH) in Taiwan to facilitate high-quality and rapid feasibility, start-up and recruitment processes. http://www.cmuh.cmu.edu.tw/ more info >> |
|
| Friday, May 18, 2018 |
|
|
Novotech稱，聯邦預算研發稅收扶持使澳大利亞在高質量臨床試驗方面具有全球競爭力 |
| 亞太地區首席技術官對特恩布爾政府的聯邦預算決定表示讚賞。該決定將臨床試驗活動排除在400萬美元的現金退款限製或最大封頂限額之外。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Doubleview Gold Corp. Reports Updated Mineral Resource Estimate as of February 25, 2026 Including a Copper Equivalent Mineral Resource: 609 (Mt) of Measured and Indicated Resources at 0.43% CuEq containing CuEq 5.82 Billion lbs. 503 (Mt) of Inferred Resources at 0.41% CuEq containing CuEq 4.57 Billion lbs
Feb 25, 2026 20:59 HKT/SGT
|
|
|
analytica Hanoi 2026 Makes Its Debut, Bringing the Global Science and Laboratory Platform to Northern Vietnam
Feb 25, 2026 19:57 HKT/SGT
|
|
|
HKTDC welcomes the 2026-27 Budget
Feb 25, 2026 18:29: JST
|
|
|
周大福人壽支持《財政預算案》有關跨境安老、落實《香港可持續披露準則》以及推動體育普及化、盛事化等措施
Feb 25, 2026 18:07 HKT/SGT
|
|
|
HKTDC welcomes the 2026-27 Budget
Feb 25, 2026 17:29 HKT/SGT
|
|
|
NEC Implements AI Code Review Service "Metabob," Reducing Technical Verification Time by Up to 66%
Feb 25, 2026 18:00 JST
|
|
|
維昇藥業（2561.HK）維臻高(R)獲批：重長效生長激素王者登場 重構百億市場的商業天花板
Feb 25, 2026 14:58 HKT/SGT
|
|
|
Shoucheng Holdings (00697.HK) Sees Long-Term International Capital Rotation as Robotics Portfolio Enters Harvest Phase
Feb 25, 2026 12:23 HKT/SGT
|
|
|
首程控股（00697.HK）迎來國際長線接盤 機器人產業生態進入價值收割期
Feb 25, 2026 12:23 HKT/SGT
|
|
|
首程控股（00697.HK）迎来国际长线接盘 机器人产业生态进入价值收割期
Feb 25, 2026 12:23 HKT/SGT
|
|
|
ベイシアのスーパーマーケット内の冷蔵・冷凍庫の温度点検・記録業務を富士通のIoT可視化ソリューションにより自動化
Feb 25, 2026 12:00: JST
|
|
|
Beisia Automates Supermarket Refrigerator Temperature Monitoring and Recording with Fujitsu's IoT Visualization Solution
Feb 25, 2026 12:00 JST
|
|
|
國泰君安國際獲批使用SIMM 衍生品風險管理接軌國際標準
Feb 25, 2026 10:34 HKT/SGT
|
|
|
国泰君安国际获批使用SIMM 衍生品风险管理接轨国际标准
Feb 25, 2026 10:34 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 22:30: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
